Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects
- PMID: 16640647
- DOI: 10.1111/j.1365-2990.2006.00727.x
Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects
Abstract
Studies on cases with incidental Lewy body disease (ILBD) suggest that alpha-synuclein (alphaSN) pathology of Parkinson's disease (PD) starts in lower brainstem nuclei and in the olfactory bulb. However, medullary structures as the induction site of alphaSN pathology have been questioned as large parts of the nervous system, including the spinal cord and the peripheral autonomic nervous system (PANS), have not been examined in ILBD. Thus, the time course of PD lesions in the spinal cord or PANS in relation to medullary lesions remains unknown. We collected 98 post mortem cases with no reference to PD-associated symptoms on clinical records. alphaSN pathology was found in the central nervous system, including the spinal cord, and in the PANS in 17 (17.3%) cases. alphaSN pathology was encountered in autonomic nuclei of the thoracic spinal cord, brainstem and olfactory nerves in 17/17, in sacral parasympathetic nuclei in 15/16, in the myenteric plexus of oesophagus in 14/17, in sympathetic ganglia in 14/17, and in the vagus nerve in 12/16 cases. In addition to the thoracic lateral horns, a high number of alphaSN lesions was also found in non-autonomic spinal cord nuclei. Considering supraspinal structures our cases corresponded roughly to the recently described sequential order of alphaSN involvement in PD. Our study indicates, however, that the autonomic nuclei of the spinal cord and the PANS belong to the most constantly and earliest affected regions next to medullary structures and the olfactory nerves. A larger cohort of ILBD cases will be needed to pinpoint the precise induction site of alphaSN pathology among these structures.
Similar articles
-
alpha-Synuclein pathology in the spinal cord autonomic nuclei associates with alpha-synuclein pathology in the brain: a population-based Vantaa 85+ study.Acta Neuropathol. 2010 Jun;119(6):715-22. doi: 10.1007/s00401-009-0629-6. Acta Neuropathol. 2010. PMID: 20037761
-
Lewy body-related α-synucleinopathy in the spinal cord of cases with incidental Lewy body disease.Neuropathology. 2012 Feb;32(1):13-22. doi: 10.1111/j.1440-1789.2011.01211.x. Epub 2011 Mar 29. Neuropathology. 2012. PMID: 22243359
-
Spinal cord lesions in sporadic Parkinson's disease.Acta Neuropathol. 2012 Nov;124(5):643-64. doi: 10.1007/s00401-012-1028-y. Epub 2012 Aug 29. Acta Neuropathol. 2012. PMID: 22926675
-
New insights into the pathology of Parkinson's disease: does the peripheral autonomic system become central?Eur J Neurol. 2008 Apr;15 Suppl 1:1-4. doi: 10.1111/j.1468-1331.2008.02057.x. Eur J Neurol. 2008. PMID: 18353130 Review.
-
A critical reappraisal of current staging of Lewy-related pathology in human brain.Acta Neuropathol. 2008 Jul;116(1):1-16. doi: 10.1007/s00401-008-0406-y. Epub 2008 Jul 1. Acta Neuropathol. 2008. PMID: 18592254 Review.
Cited by
-
Comparison of alpha-synuclein immunoreactivity in the spinal cord between the adult and aged beagle dog.Lab Anim Res. 2012 Sep;28(3):165-70. doi: 10.5625/lar.2012.28.3.165. Epub 2012 Sep 26. Lab Anim Res. 2012. PMID: 23091516 Free PMC article.
-
Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease.Parkinsons Dis. 2011 Feb 17;2011:708404. doi: 10.4061/2011/708404. Parkinsons Dis. 2011. PMID: 21403906 Free PMC article.
-
α-Synuclein and mitochondrial dysfunction in Parkinson's disease.Mol Neurobiol. 2013 Apr;47(2):587-97. doi: 10.1007/s12035-013-8394-x. Epub 2013 Jan 30. Mol Neurobiol. 2013. PMID: 23361255 Free PMC article. Review.
-
Plasma Metabolic Analysis Reveals the Dysregulation of Short-Chain Fatty Acid Metabolism in Parkinson's Disease.Mol Neurobiol. 2023 May;60(5):2619-2631. doi: 10.1007/s12035-022-03157-y. Epub 2023 Jan 24. Mol Neurobiol. 2023. PMID: 36690885
-
Molecular and clinical prodrome of Parkinson disease: implications for treatment.Nat Rev Neurol. 2010 Jun;6(6):309-17. doi: 10.1038/nrneurol.2010.52. Epub 2010 May 18. Nat Rev Neurol. 2010. PMID: 20479780 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources